Additionally, Ginsenoside Rg1 reduces the production of inflammatory cytokines like interleukin 1 (IL-1) and interleukin 18 (IL-18), thereby alleviating NAFLD through its anti-inflammatory function [138]. This evidence concerns the gene IL18 and metabolic dysfunction-associated steatotic liver disease.